Huadao Biopharma

Shanghai, China · Founded 2017 · Privately Held (backing)

Developer of cell immunotherapy technology designed for oncology. Huadao Biopharma is based in Shanghai, China and was founded in 2017. Its last reported valuation was $79.9 million in Jul 2019. It has raised $58.8 million.

Last reported valuation

$79.9M

Oct 2026

Priced at

—

Total raised

$58.8M

Last round

—

How much has Huadao Biopharma raised?

$58.8Macross 0 recorded rounds

Free account

More of Huadao Biopharma with a free account

·The complete investor list: 20 names
·Watch Huadao Biopharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Huadao Biopharma investors

20 investors are on record for Huadao Biopharma, including Hankang Capital, Shanghai Songjiang State-owned Assets Investment, Jiaxing Jiarui Investment Management and Zhejiang Haiyue Asset Management.

For fundraisers

Raising for a company like Huadao Biopharma?

20 investors have backed Huadao Biopharma.

See all 20 investors →

Frequently asked about Huadao Biopharma

How much has Huadao Biopharma raised?: Huadao Biopharma has raised $58.8M in total across 0 recorded funding rounds.